ASCENDIS PHARMA A/S -

New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)

13 5 2025 13:01:00 提供 Nasdaq GlobeNewswire

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

12 5 2025 13:45:30 提供 Nasdaq GlobeNewswire

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025

05 5 2025 05:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

02 5 2025 06:45:50 提供 NetDania Notify

Ascendis Pharma Reports First Quarter 2025 Financial Results

01 5 2025 13:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

01 5 2025 06:45:35 提供 NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

30 4 2025 10:59:46 提供 NetDania Notify

Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

24 4 2025 13:01:00 提供 Nasdaq GlobeNewswire

Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia

31 3 2025 13:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

17 3 2025 06:45:02 提供 NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

03 3 2025 06:45:07 提供 NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

28 2 2025 09:27:23 提供 NetDania Notify

Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference

24 2 2025 13:01:00 提供 Nasdaq GlobeNewswire

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs

12 2 2025 13:05:00 提供 Nasdaq GlobeNewswire

Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results

12 2 2025 13:01:00 提供 Nasdaq GlobeNewswire

Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025

05 2 2025 13:01:00 提供 Nasdaq GlobeNewswire

Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference

12 1 2025 14:00:00 提供 Nasdaq GlobeNewswire

Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

06 1 2025 05:30:00 提供 Nasdaq GlobeNewswire

YORVIPATH® (Palopegteriparatide) Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in Adults

19 12 2024 05:30:00 提供 Nasdaq GlobeNewswire

New InsiGHTS Trial of TransCon™ hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26

16 12 2024 05:30:00 提供 Nasdaq GlobeNewswire